PINC vs. INDV, JANX, QDEL, SMMT, CGON, RYTM, HIMS, MRUS, CORT, and ICUI
Should you be buying Premier stock or one of its competitors? The main competitors of Premier include Indivior (INDV), Janux Therapeutics (JANX), QuidelOrtho (QDEL), Summit Therapeutics (SMMT), CG Oncology (CGON), Rhythm Pharmaceuticals (RYTM), Hims & Hers Health (HIMS), Merus (MRUS), Corcept Therapeutics (CORT), and ICU Medical (ICUI). These companies are all part of the "medical" sector.
Premier (NASDAQ:PINC) and Indivior (NASDAQ:INDV) are both mid-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, institutional ownership, media sentiment, community ranking, dividends, risk and profitability.
Premier has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Comparatively, Indivior has a beta of 0.46, suggesting that its share price is 54% less volatile than the S&P 500.
In the previous week, Indivior had 5 more articles in the media than Premier. MarketBeat recorded 12 mentions for Indivior and 7 mentions for Premier. Premier's average media sentiment score of 0.51 beat Indivior's score of -0.28 indicating that Premier is being referred to more favorably in the media.
Premier presently has a consensus target price of $25.15, suggesting a potential upside of 19.88%. Indivior has a consensus target price of $36.00, suggesting a potential upside of 103.05%. Given Indivior's stronger consensus rating and higher probable upside, analysts clearly believe Indivior is more favorable than Premier.
Premier received 609 more outperform votes than Indivior when rated by MarketBeat users. However, 100.00% of users gave Indivior an outperform vote while only 69.35% of users gave Premier an outperform vote.
74.4% of Premier shares are owned by institutional investors. Comparatively, 60.3% of Indivior shares are owned by institutional investors. 0.9% of Premier shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.
Premier has higher revenue and earnings than Indivior. Premier is trading at a lower price-to-earnings ratio than Indivior, indicating that it is currently the more affordable of the two stocks.
Premier has a net margin of 12.71% compared to Indivior's net margin of 0.44%. Indivior's return on equity of 842.72% beat Premier's return on equity.
Summary
Indivior beats Premier on 9 of the 17 factors compared between the two stocks.
Get Premier News Delivered to You Automatically
Sign up to receive the latest news and ratings for PINC and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding PINC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
